Factors Associated with Decisions to Attend Cervical Cancer Screening among Women Aged 30-60 Years in Chatapadung Contracting Medical Unit, Thailand

  • Budkaew, Jiratha (Department of Social Medicine, Khon Kaen Center Hospital, Khon Kaen University) ;
  • Chumworathayi, Bandit (Department of Obstetrics and Gynecology, Srinagarind Hospital, Khon Kaen University)
  • Published : 2014.06.30


Background: This study aimed to identify factors associated with women's decisions to attend cervical cancer screening and to explore those linked with intention to attend in the coming year and to continue regular screening. Materials and Methods: A community based case-control study was conducted among woman 30-60 years of age in catchment area of Chatapadung Contracting Medical Unit (CCMU), networking of Khon Kaen Center Hospital, Thailand. Self-administered questionnaires were used to collect data, and in-depth interviews were then performed to explore in greater detail. Results: There were 195 participants. Only one third (32.3 %) had been screened for cervical cancer within the past 5 years. Some 67.7% reported that they had not been screened because they had no abnormal symptoms, single marital status, and no children. Only 10.6% of those never had screening intent to be screened within the next 12 months. High family income (adjusted OR=2.16, 95%CI=1.13-4.14), good attitude towards a Pap test (OR=1.87, 95%CI=1.09-4.23), and having received a recommendation from health care providers were important factors associated with decisions to attend cervical cancer screening (OR=1.73, 95%CI=1.01-4.63). From in-depth interviews, there were five reasons of their decisions to attend cervical cancer screening including yearly check-up, postpartum check-up, having abnormal symptom, encouragement by health care providers, and request from workplace. Conclusions: High family income, good attitude towards a Pap test, and receiving proper recommendation by health care providers, were important factors associated with decision to have cervical cancer screening among women 30-60 years old. Trying to enhance these factors and reduce barriers regarding screening, may increase the coverage rate for cervical cancer screening in Thailand.


  1. Pornpikanon S (2008). Effective factors of women to take cervical cancer screening between 35-39 years of age in Sriracha district, Chonburi province. [Master's thesis]. Chonburi: Burapha University.
  2. Suthipinthawong C, Siriaunkul S, Tungsinmunkong K, et al (2011). HPV prevalence, genotype distribution, and pattern of infection in Thai women. Asian Pac J Cancer Prev, 12, 854-6.
  3. Taylor VM, Yasui Y, Burke N, et al (2004). Pap testing adherence among Vietnamese American women. Cancer Epidemiol Biomarkers Prev, 13, 613-9.
  4. WHO (World Health Organization) (2013). Comprehensive cervical cancer prevention and control: a healthier future for girls and women. Geneva: WHO.
  5. Martin N, Patel N (2003). Cancer incidence in Thailand. In. Sriplung H, Sontipong S, Martin N, et al, editors. Cancer in Thailand Vol III, 1995-1997. Lyon: IARC.
  6. Paul P, LaMontagne SD, Le TN (2012). Knowledge of cervical cancer and HPV vaccine post-vaccination among mothers and daughters in Vietnam. Asian Pac J Cancer Prev, 13, 2588-92.
  7. Pornsinsiriruck S (2007). Factors related to cervical cancer behavior of Thai Muslim women in Krabi province. [Master's thesis]. Bangkok: Mahidol University.
  8. Richart R (1998). Cervical cancer in developing countries. In. Special Challenges in Third World Women's Health. New York: International Women's Health Coalition.
  9. Saslow D, Runowicz CD, Solomon D, et al. (2002). American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA: Cancer J Clin, 52, 342-62.
  10. Schlesselman JJ (1982). Case-control studies: design, conduct, analysis. New York: Oxford University Press.
  11. Srichan Y (2007). Effective factors of women to take cervical cancer screening in Pasak district, Poosang sub-district, Payao province. [Master's thesis]. Chaingmai: Chaingmai University.
  12. Srisakul S, Nirattharadorn M, Suwannarurk K (2011). Factors predicting intention for cervical cancer screening among women aged 30 to 60 years in Ratchaburi province, Thailand: population-based study. Thammasat Med J, 11, 4.
  13. Swangvaree SS, Tangprasert N, Adulphan A, et al (2010). Cervical cancer survival at the National Cancer Institute, Thailand. Thai Cancer J, 30, 87-93.
  14. Swangvaree SS, Kongkaew P, Rungsuj P, Saruk O (2010). Prevalence of high risk human papilloma virus infection and cytologic result in Thailand. Asian Pac J Cancer Prev, 11, 1465-8
  15. Canavan TP, Doshi NR (2000). Cervical cancer. Am Fam Physician, 61, 1369-76.
  16. Armstrong EP (2010). Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Managed Care Pharmacy, 16, 217-30.
  17. Attasara P, Sriplung H (2013). Cancer incidence in Thailand. In. Khuhaprema T, Attasara P, Sriplung H, et al, editors. Cancer in Thailand Vol VII, 2007-2009. Bangkok: Thai National Cancer Institute.
  18. Behbakht K, Lynch A, Teal S, Degeest K, Massad S (2004). Social and cultural barriers to Papanicolaou test screening in an urban population. Am Coll Obstet Gynaecol, 104, 1355-61.
  19. Chesun A, Harncharoen K, Taechaboonsermsak P, Siri S (2012). Factors related with cervical cancer screening test among Thai Muslim women in Satun province. Asia J Public Health, 3, 79-85.
  20. Chiamchanya C, Suwannarurk K, Kietinun S (2004). The screening cervical cancer by Pap smear in women age 15-65 Years in Tambol Ku-kot, Lumlukka district, Pathumthani province. Thammasat Med J, 1, 20-32.
  21. Elovainio L, Nieminen P, Miller A (1997). Impact of cancer screening on women's health. Int J Gynecol Obstet, 58, 139.
  22. Helen C (2013). Factors associated with cervical cancer screening uptake among Inuit women in Nunavik, Quebec, Canada. BMC Public Health, 13, 438.
  23. Hislop TG, Deschamps M, Teh C, et al (2003). Facilitators and barriers to cervical cancer screening among Chinese Canadian women. Can J Public Health, 94, 68-73.
  24. Lin SJ (2008). Factors influencing the uptake of screening services for breast and cervical cancer in Taiwan. J R Soc Promot Health, 128, 327-34.
  25. Abdul Rashid RM, Dahlui M (2013). Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia. Asian Pac J Cancer Prev, 14, 5867-70.
  26. Al-Naggar RA, Low WY, Isa ZM (2010). Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac J Cancer Prev, 11, 867-73.
  27. Arbyn M, Anttila A, Jordan J, et al (2010). European guidelines for quality assurance in cervical cancer screening, second edition---summary document. Ann Oncol, 21, 448-58.

Cited by

  1. Challenges of Providing Cervical Cancer Prevention Programs In Iran: A Qualitative Study vol.15, pp.23, 2015,
  2. Single Life Time Cytological Screening in High Risk Women as an Economical and Feasible Approach to Control Cervical Cancer in Developing Countries Like India vol.16, pp.3, 2015,
  3. Knowledge, Attitudes and Practices Regarding Cervical Cancer Screening Among Village Health Volunteers vol.16, pp.7, 2015,
  4. Proximity of Health Care Center and Cervical Cancer Screening Uptake in Thailand vol.16, pp.7, 2015,
  5. Knowledge, Attitudes and Behavior of Bangkok Metropolitan Women Regarding Cervical Cancer Screening vol.17, pp.3, 2016,